ACAD
34.93
-0.08
-0.23%
AEMD
3.65
-0.32
-8.13%
APRI
2.26
+0.04
+1.80%
ARNA
1.43
-0.01
-0.69%
ATEC
2.68
-0.12
-4.29%
CNAT
4.4
-0.02
-0.45%
CRXM
0.21
0.00
0.00%
CYTX
1.61
-0.03
-1.83%
DXCM
76.9
+0.41
+0.54%
GNMK
13.02
+0.14
+1.09%
HALO
13.49
+0.2
+1.50%
ILMN
167.79
+4.29
+2.62%
INNV
0.104
+0.001
+0.971%
INO
5.92
+0.06
+1.02%
ISCO
1.75
+0.15
+9.38%
ISIS
57.56
0.00
0.00%
LGND
104.07
+0.02
+0.02%
LPTN
2.93
0.00
0.00%
MBVX
2.45
-0.07
-2.78%
MEIP
1.54
-0.04
-2.53%
MNOV
5.8
-0.01
-0.17%
MRTX
5.15
-0.05
-0.96%
MSTX
0.098
-0.005
-4.6921%
NBIX
41.72
-0.05
-0.12%
NUVA
74.55
+0.42
+0.57%
ONCS
1.26
-0.03
-2.33%
ONVO
3.01
0.00
0.00%
OREX
4
-0.08
-1.96%
OTIC
13.15
+0.9
+7.35%
QDEL
21.31
-0.17
-0.79%
RCPT
231.96
0.00
0.00%
RGLS
1.25
+0.05
+4.17%
RMD
71.29
+0.57
+0.81%
SPHS
2.55
+0.01
+0.39%
SRNE
4.15
0.00
0.00%
TROV
1
-0.08
-6.98%
VICL
2.18
+0.02
+0.93%
VOLC
18
0.00
0.00%
ZGNX
10.35
0.00
0.00%
ACAD
34.93
-0.08
-0.23%
AEMD
3.65
-0.32
-8.13%
APRI
2.26
+0.04
+1.80%
ARNA
1.43
-0.01
-0.69%
ATEC
2.68
-0.12
-4.29%
CNAT
4.4
-0.02
-0.45%
CRXM
0.21
0.00
0.00%
CYTX
1.61
-0.03
-1.83%
DXCM
76.9
+0.41
+0.54%
GNMK
13.02
+0.14
+1.09%
HALO
13.49
+0.2
+1.50%
ILMN
167.79
+4.29
+2.62%
INNV
0.104
+0.001
+0.971%
INO
5.92
+0.06
+1.02%
ISCO
1.75
+0.15
+9.38%
ISIS
57.56
0.00
0.00%
LGND
104.07
+0.02
+0.02%
LPTN
2.93
0.00
0.00%
MBVX
2.45
-0.07
-2.78%
MEIP
1.54
-0.04
-2.53%
MNOV
5.8
-0.01
-0.17%
MRTX
5.15
-0.05
-0.96%
MSTX
0.098
-0.005
-4.6921%
NBIX
41.72
-0.05
-0.12%
NUVA
74.55
+0.42
+0.57%
ONCS
1.26
-0.03
-2.33%
ONVO
3.01
0.00
0.00%
OREX
4
-0.08
-1.96%
OTIC
13.15
+0.9
+7.35%
QDEL
21.31
-0.17
-0.79%
RCPT
231.96
0.00
0.00%
RGLS
1.25
+0.05
+4.17%
RMD
71.29
+0.57
+0.81%
SPHS
2.55
+0.01
+0.39%
SRNE
4.15
0.00
0.00%
TROV
1
-0.08
-6.98%
VICL
2.18
+0.02
+0.93%
VOLC
18
0.00
0.00%
ZGNX
10.35
0.00
0.00%
Home » Archive by Category

Xconomy

Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit

March 22, 2017 – 3:15 am

Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us…

[[Click headline to continue reading.]]

Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs

March 20, 2017 – 6:41 am

Cerulean Pharma may have been able to survive one brush with death, but the second has proven fatal. Today, the Waltham, MA, company announced plans to merge with a privately held women’s health…

[[Click headline to continue reading.]]

With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work

March 17, 2017 – 4:55 am

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more…

[[Click headline to continue reading.]]

Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More

March 17, 2017 – 2:50 am

If it wasn’t clear that the Trump administration disdained most types of scientific inquiry and practice, the White House’s proposed budget drove the point home. The top-line figures: a…

[[Click headline to continue reading.]]

CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants

March 15, 2017 – 9:38 pm

One of the companies trying to revive the once-failed notion of xenotransplantation—transplanting animal organs or tissues into humans—has raised a significant round of cash. The $38…

[[Click headline to continue reading.]]

Human Longevity Offers Genome Sequencing Through MassMutual

March 14, 2017 – 9:00 pm

Human Longevity Inc., founded in 2014 by the gene pioneer J. Craig Venter to create a database for interpreting the human genome (and to make healthcare more proactive instead of reactive) said it…

[[Click headline to continue reading.]]

Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed?

March 13, 2017 – 1:35 am

It’s a struggle that comic-book fans know well. Ordinary people, bestowed with super powers from a spider bite or gamma rays, struggle to harness their own abilities. T cells, key soldiers of…

[[Click headline to continue reading.]]

Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales

March 10, 2017 – 1:05 pm

[Updated 3/12/17 with more comments, see below] The Trump administration has nominated Scott Gottlieb to be the new commissioner of the FDA, a selection that had the life sciences industry breathing…

[[Click headline to continue reading.]]

Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer

March 10, 2017 – 10:46 am

[Corrected 3/10/17, 3:27 pm. See below] Gene therapy developer Tocagen is preparing an initial public stock offering to finance clinical trials of its experimental treatment for a form of brain…

[[Click headline to continue reading.]]

Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More

March 10, 2017 – 4:36 am

We’ll start the roundup in Washington DC. The repeal of the Affordable Care Act, also known as Obamacare, began on the first day of the Trump administration. This week, the “replace”…

[[Click headline to continue reading.]]